TY  - GEN
AU  - Puente, Javier
AU  - Gonzalez-del-Alba, Aranzazu
AU  - Sala-Gonzalez, Nuria
AU  - Jose Mendez-Vidal, Maria
AU  - Pinto, Alvaro
AU  - Rodriguez, Angel
AU  - Cuevas Sanz, Jose Miguel
AU  - Rodrigo Munoz del Toro, Jacobo
AU  - Rodriguez, Eduardo Useros
AU  - Garcia Garcia-Porrero, Angela
AU  - Vazquez, Sergio
PY  - 2019
DO  - 10.1186/s12885-019-5974-9
UR  - https://hdl.handle.net/20.500.12105/22660
AB  - Background: To describe the patterns of second-line treatment of patients with metastatic castration-resistant prostate cancer (mCRPC) after docetaxel treatment in a Spanish population, to identify the factors associated with those patterns, and to...
LA  - eng
PB  - BioMed Central (BMC)
KW  - Metastatic castration-resistant prostate cancer
KW  - Abiraterone acetate
KW  - Cabazitaxel
KW  - Chemotherapy
KW  - Sequence
TI  - Efficacy and safety of abiraterone acetate plus prednisone vs. cabazitaxel as a subsequent treatment after first-line docetaxel in metastatic castration-resistant prostate cancer: results from a prospective observational study (CAPRO)
TY  - research article
ER  -